UnitedHealth Group Inc. (UNH) Shares Sold by Vontobel Asset Management Inc.
Vontobel Asset Management Inc. decreased its stake in UnitedHealth Group Inc. (NYSE:UNH) by 3.9% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,867,387 shares of the healthcare conglomerate’s stock after selling 74,855 shares during the period. UnitedHealth Group accounts for 2.1% of Vontobel Asset Management Inc.’s holdings, making the stock its 17th largest position. Vontobel Asset Management Inc. owned approximately 0.20% of UnitedHealth Group worth $270,250,000 as of its most recent filing with the SEC.
A number of other hedge funds also recently made changes to their positions in the company. Chevy Chase Trust Holdings Inc. boosted its position in UnitedHealth Group by 2.7% in the second quarter. Chevy Chase Trust Holdings Inc. now owns 1,095,944 shares of the healthcare conglomerate’s stock valued at $154,747,000 after buying an additional 28,945 shares in the last quarter. Exxonmobil Investment Management Inc. TX boosted its position in UnitedHealth Group by 6.3% in the second quarter. Exxonmobil Investment Management Inc. TX now owns 246,116 shares of the healthcare conglomerate’s stock valued at $34,752,000 after buying an additional 14,650 shares in the last quarter. DNB Asset Management AS boosted its position in UnitedHealth Group by 5.1% in the second quarter. DNB Asset Management AS now owns 573,902 shares of the healthcare conglomerate’s stock valued at $81,035,000 after buying an additional 27,800 shares in the last quarter. Daiwa SB Investments Ltd. purchased a new position in UnitedHealth Group during the second quarter valued at $6,183,000. Finally, Washington Trust Bank boosted its position in UnitedHealth Group by 0.4% in the second quarter. Washington Trust Bank now owns 29,319 shares of the healthcare conglomerate’s stock valued at $4,140,000 after buying an additional 109 shares in the last quarter. Hedge funds and other institutional investors own 86.04% of the company’s stock.
UnitedHealth Group Inc. (NYSE:UNH) traded down 0.48% during mid-day trading on Friday, hitting $152.81. The stock had a trading volume of 1,664,542 shares. The company’s 50 day moving average price is $143.37 and its 200 day moving average price is $139.61. The firm has a market cap of $145.27 billion, a PE ratio of 25.43 and a beta of 0.63. UnitedHealth Group Inc. has a 52 week low of $107.51 and a 52 week high of $154.50.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, October 18th. The healthcare conglomerate reported $2.17 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.08 by $0.09. The business had revenue of $46.30 billion for the quarter, compared to analysts’ expectations of $46.09 billion. UnitedHealth Group had a return on equity of 19.92% and a net margin of 3.62%. The firm’s quarterly revenue was up 11.6% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.77 EPS. Analysts anticipate that UnitedHealth Group Inc. will post $8.01 earnings per share for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 13th. Investors of record on Friday, December 2nd will be issued a dividend of $0.625 per share. The ex-dividend date of this dividend is Wednesday, November 30th. This represents a $2.50 dividend on an annualized basis and a yield of 1.64%. UnitedHealth Group’s dividend payout ratio (DPR) is 36.93%.
Several equities analysts recently weighed in on UNH shares. Mizuho cut shares of UnitedHealth Group from a “buy” rating to a “neutral” rating in a research note on Wednesday, November 9th. Leerink Swann reissued an “outperform” rating on shares of UnitedHealth Group in a research note on Sunday, August 21st. Sanford C. Bernstein reissued an “outperform” rating and issued a $178.00 target price on shares of UnitedHealth Group in a research note on Tuesday, September 6th. Vetr raised shares of UnitedHealth Group from a “buy” rating to a “buy” rating in a research note on Friday, October 7th. Finally, Jefferies Group reissued a “buy” rating and issued a $163.00 target price on shares of UnitedHealth Group in a research note on Tuesday, October 4th. Two research analysts have rated the stock with a hold rating and twenty-two have given a buy rating to the stock. UnitedHealth Group has a consensus rating of “Buy” and an average target price of $158.03.
In related news, Director Kenneth Irwin Shine sold 325 shares of the stock in a transaction dated Friday, October 21st. The stock was sold at an average price of $144.99, for a total transaction of $47,121.75. Following the sale, the director now owns 28,613 shares of the company’s stock, valued at approximately $4,148,598.87. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Gail R. Wilensky sold 5,460 shares of the stock in a transaction dated Thursday, November 17th. The stock was sold at an average price of $150.55, for a total value of $822,003.00. Following the sale, the director now directly owns 60,052 shares in the company, valued at approximately $9,040,828.60. The disclosure for this sale can be found here. Corporate insiders own 1.65% of the company’s stock.
About UnitedHealth Group
UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Stock Ratings for UnitedHealth Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Inc. and related stocks with our FREE daily email newsletter.